Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 6,622

According to reports, Samsung will increase the proportion of Exynos chips used in its own models in 2022 to reduce its dependence on Qualcomm chips. Samsung’s use of Exynos chips in its own models will increase by about 2–3 times next year. At the same time, Samsung has set a sales target of 300 million mobile phones next year.

Industry insiders pointed out that Samsung is vigorously supporting Exynos chips. On the one hand, it will increase the proportion of Exynos chips in its own models. On the other hand, it is open to partners. Recall that the company co-developed the Exynos 1,080 chip with Vivo which the latter used in the Vivo X60 series.

Read more | >

Stethoscopes are among doctors’ most important instruments, yet there have not been any essential improvements to the device since the 1960s. Now, researchers at Aalto University have developed a device that analyzes a broad range of bodily functions and offers physicians a probable diagnosis as well as suggestions for appropriate further examinations. The researchers believe that the new device could eventually replace the stethoscope and enable quicker and more precise diagnoses.

A startup called Vital Signs is taking the device to the market. The researchers are currently testing the device in a clinical pilot trial. The intention is to launch the product to the most important European markets by the end of 2023.

“We have a well-functioning prototype, and the development path is clear,” says Alexis Kouros, the doctor leading the research team at Aalto.

Read more | >

PBS Member Stations rely on viewers like you. To support your local station, go to: http://to.pbs.org/DonateSPACE
↓ More info below ↓

Erratum: Figures in episode should be Minev et al. (2019), not Minney et al. (2009). Our apologies to the authors!

This is the experiment we talk about:
To Catch and Reverse a Quantum Jump Mid-Flight.
Minev, Mundhada, Shankar, Reinhold, Gutiérrez-Jáuregui, Schoelkopf.
Mirrahimi, Carmichael & Devoret (2019), Nature, v.570, p.200
https://doi.org/10.1038/s41586-019-1287-z.

Sign Up on Patreon to get access to the Space Time Discord!
https://www.patreon.com/pbsspacetime.

Since the very beginning of quantum mechanics, a debate has raged about how to interpret its bizarre predictions. And at the heart and origin of that debate is the quantum jump or quantum leap — the seemingly miraculous and instantaneous transitions of quantum systems that have always defied observation or prediction. At least, until now.

Check out the Space Time Merch Store.

Continue reading “What Happens During a Quantum Jump?” | >

Markets plunged on Friday, hope of taming the coronavirus dimmed and a new term entered the pandemic lexicon: Omicron.

The Covid-19 variant that emerged in South Africa was named after the 15th letter of the Greek alphabet.

The naming system, announced by the World Health Organization in May, makes public communication about variants easier and less confusing, the agency and experts said.

Read more | >

Pfizer is confident its COVID-19 antiviral pill, Paxlovid, will be effective against the new omicron variant, the drugmaker’s CEO told CNBC Nov. 29.

The omicron strain, first detected in South Africa, contains 32 mutations in the spike protein, and while preliminary evidence suggests the strain may increase the risk of reinfection, it’s still uncertain how the variant may affect illness severity or the effectiveness of vaccines and treatments.

Albert Bourla, PhD, Pfizer’s CEO, told CNBC the company’s antiviral was created with the spike protein in mind and expects it will work against omicron.

Read more | >